Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

PURPOSE: Circulating tumor DNA (ctDNA) sequencing provides a minimally invasive method for tumor molecular stratification. Commercial ctDNA sequencing is increasingly used in the clinic, but its accuracy in metastatic prostate cancer is untested. We compared the commercial Guardant360 ctDNA test aga...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Taavitsainen, Sinja, Annala, Matti, Ledet, Elisa, Beja, Kevin, Miller, Patrick J., Moses, Marcus, Nykter, Matti, Chi, Kim N., Sartor, Oliver, Wyatt, Alexander W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Original Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446428/
https://ncbi.nlm.nih.gov/pubmed/32914020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados